All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Source link : http://pink.citeline.com/PS148736/Swiss-New-Drug-Approval-Times-On-A-Par-With-EMA-But-Longer-Than-US-FDA
Author :
Publish date : 2023-09-29 18:10:27
Copyright for syndicated content belongs to the linked Source.
Source link : https://news.google.com/rss/articles/CBMieEFVX3lxTFBMdXpnYTA4S2o5TXZiWlpGQm1XRnZnLXR0TEdEYWNTc1ZmdTg4RVhVWTZzaXJKT3ZGMUxMSUpsSFJ6TnlSY1VROXJ4TmtaeHcwU1JEbzBEVWtRUlFPZnpVb0xtNjJudGVWWk5uN1pCVm9nbDh2MHcwcw?oc=5 Author : Publish date : 2025-01-20 05:28:00 Copyright for syndicated content belongs to the linked Source.
Source link : https://news.google.com/rss/articles/CBMimwFBVV95cUxPVjRpMnJBSEc0ZjI3dlBJVWhuTVNCb0NrTDByREVjaGl1MEVEanFZVG5XUkh2SVhEOWtCSFVReWpZbmZOSER6bE0yOXpSb0JpOXpmQktUdHlyZ2o5OVBoTjhQZThBRUYyYmU5TUs3cVl4bUZHNTJMS0NyZjJTTnVzY2Zrb3JIbkhHemY2ZklwdjBhRFA5YVMtbEdEMNIBoAFBVV95cUxNWlJrdU02THdRSk1MeHI5TDhhVFhoZHlJVXJfOUpEZlpPZkk2OHNrSVc1aFVKZHdmeGlsRGtXSUtVcWNKTkVYWEl6UkJRbmxJVzhQdk9LM25YSm5uTVAxVzVVRkd1aTRhd0FvT2VXaXlzOERXQ01RMS0yaXJDRllydnJWd19GQjBiMzQzVVpYa2JhTDIxUjY2aGQ4NzVLdjk3?oc=5 Author : Publish date : 2025-01-19 22:37:00 Copyright for syndicated content belongs to the linked Source.
Source link : https://news.google.com/rss/articles/CBMiuAFBVV95cUxPREphME9VOWZpU29TWEFOVHRDMksyZDdraEpEOUVrejRsTFlxd2JBTXEwS3Rpcmw5aEluSDZZUmFqcHJHT1d4eWNJVUUwazVmSHZmdzNZTHdtM0Y1Qkt2OG9jRWMzRk5mZVc1b255YVBrd21xdDFadXJsM1pYS1hfdGthTU1DUG9TSEtIZUFxRG9Ra3JqSVYyS1pMMko4WVc5dFFKSDFFUFFLZlZTbExjZmZTNDQ4RGlm?oc=5 Author : Publish date : 2025-01-19 20:20:00 Copyright for syndicated content belongs to the linked Source.
..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....
